ASCL1 is also known as a repressive target of Smad TFs downstream of transforming growth factor‐β (TGF‐β) and is required for tumor formation by suppressing apoptosis in SCLC cells (Murai et al., 2015). The gene discussed is TGFB1; the disease is neoplasm.